These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22758205)

  • 1. Elevated HSP27 levels during attacks in patients with multiple sclerosis.
    Li HF; Zhang HL
    Acta Neurol Scand; 2012 Aug; 126(2):e8-9. PubMed ID: 22758205
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated HSP27 levels during attacks in patients with multiple sclerosis.
    Ce P; Erkizan O; Gedizlioglu M
    Acta Neurol Scand; 2011 Nov; 124(5):317-20. PubMed ID: 21208199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis.
    Pasquali L; Lucchesi C; Pecori C; Metelli MR; Pellegrini S; Iudice A; Bonuccelli U
    J Neuroimmunol; 2015 Jan; 278():53-9. PubMed ID: 25595252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
    Börnsen L; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
    Mult Scler; 2011 Jan; 17(1):32-42. PubMed ID: 20921238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of soluble interleukin-6 receptor in inflammatory diseases.
    Maggio M; Basaria S; Ceda GP; Ceresini G; Valenti G; Ferrucci L
    Immunol Lett; 2005 Apr; 98(1):171. PubMed ID: 15790523
    [No Abstract]   [Full Text] [Related]  

  • 6. Prothrombin and factor X are elevated in multiple sclerosis patients.
    Göbel K; Kraft P; Pankratz S; Gross CC; Korsukewitz C; Kwiecien R; Mesters R; Kehrel BE; Wiendl H; Kleinschnitz C; Meuth SG
    Ann Neurol; 2016 Dec; 80(6):946-951. PubMed ID: 27774643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
    J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raised endothelial microparticles an early marker for multiple sclerosis?
    Larkin M
    Lancet; 2001 May; 357(9269):1679. PubMed ID: 11425383
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
    Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
    J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis.
    Wilczak N; Ramsaransing GS; Mostert J; Chesik D; De Keyser J
    Mult Scler; 2005 Feb; 11(1):13-5. PubMed ID: 15732261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotropic herpesviruses in multiple sclerosis.
    Hay KA; Tenser RB
    Mult Scler; 2000 Apr; 6(2):66-8. PubMed ID: 10773849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis].
    Bilińska M; Frydecka I; Kosmaczewska A; Ciszak L; Koszewicz M; Pokryszko-Dragan A
    Pol Merkur Lekarski; 2006 Jan; 20(115):41-5. PubMed ID: 16617733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Lanzillo R; Di Somma C; Quarantelli M; Ventrella G; Gasperi M; Prinster A; Vacca G; Pivonello C; Orefice G; Colao A; Morra VB
    Eur J Neurol; 2011 Dec; 18(12):1402-6. PubMed ID: 21585623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Clin Immunol; 2006 Jan; 118(1):77-82. PubMed ID: 16275091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum homocysteine levels in relation to clinical progression in multiple sclerosis.
    Teunissen CE; Killestein J; Kragt JJ; Polman CH; Dijkstra CD; Blom HJ
    J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1349-53. PubMed ID: 18676406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients.
    Sfagos C; Makis AC; Chaidos A; Hatzimichael EC; Dalamaga A; Kosma K; Bourantas KL
    Mult Scler; 2005 Jun; 11(3):272-5. PubMed ID: 15957506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.
    Alexander JS; Chervenak R; Weinstock-Guttman B; Tsunoda I; Ramanathan M; Martinez N; Omura S; Sato F; Chaitanya GV; Minagar A; McGee J; Jennings MH; Monceaux C; Becker F; Cvek U; Trutschl M; Zivadinov R
    J Neurol Sci; 2015 Aug; 355(1-2):84-9. PubMed ID: 26073484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse.
    Miranda Acuña J; Hidalgo de la Cruz M; Ros AL; Tapia SP; Martínez Ginés ML; de Andrés Frutos CD
    Mult Scler Relat Disord; 2017 Nov; 18():157-160. PubMed ID: 29141800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of nitric oxide metabolites in the serum of Iranian multiple sclerosis patients.
    Roghani M; Mahboudi F; Saharian MA; Etemadifar M; Esfahani AN; Nahrevanian H; Elahi E
    J Neurol Sci; 2010 Jul; 294(1-2):92-4. PubMed ID: 20434172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.